PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'1st Cardiology Department, \'Hippokration\' General Hospital, School of Medicine, National and Kapodistrian University of Athens, 11527 Athens, Greece.\', \'Radcliffe Department of Medicine, Division of Cardiovascular Medicine, University of Oxford, Oxford OX3 9DU, UK.\', \'Oxford Centre of Research Excellence, British Heart Foundation, Oxford OX3 9DU, UK.\', \'Oxford Biomedical Research Centre, National Institute of Health Research, Oxford OX3 9DU, UK.\', \'Department of Cardiovascular and Thoracic Sciences, Catholic University, 00168 Rome, Italy.\', \'Molecular and Clinical Sciences Research Institute, St George\'s University of London, London SW17 0RE, UK.\']
?:citedBy
  • -1
?:creator
?:doi
  • 660710.3390/ijms22126607
?:doi
?:hasPublicationType
?:journal
  • International journal of molecular sciences
is ?:pmid of
?:pmid
?:pmid
  • 34205487
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.26
?:rankingScore_hIndex
  • 95
is ?:relation_isRelatedTo_publication of
?:title
  • Inflammatory Mechanisms in COVID-19 and Atherosclerosis: Current Pharmaceutical Perspectives.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all